Medtronic taps Dr. Elizabeth Nabel, president of Brigham & Women's Faulkner Hospital in Boston, for a seat on its board of directors.
Merging medtech titans Medtronic and Covidien are preparing to host the 1st of 4 Integration Summits, scheduled later this month.
A senior executive at Medtronic, vice president of corporate development Chris Cleary, explains how Covidien played "scrappy" upstart all the way to a $43 billion payout.
Minnesota medtech giant Medtronic launches its Kyphon Express II balloon kyphoplasty system for treating vertebral compression fractures.
Medtronic (NYSE:MDT) officially launched the latest in its line of balloon kyphoplasty (BKP) technologies, the Kyphon Express II, for use in treating vertebral compression fractures.
Another trial of Medtronic's Symplicity renal denervation device in treating hypertension shows no benefit compared with a sham procedure.
Integra LifeSciences agrees to pay $60 million to acquire a pair of Medtronic's ear, nose & throat instrument lines.
New results from Medtronic's OpT2mise clinical trial find that Type 2 diabetics with insulin pumps are happier with their therapy than those relying on multiple daily injections.
Insulin pumps beat manual injections for managing symptoms of Type 2 diabetes, according to the latest results from Medtronic's (NYSE:MDT) OpT2mise clinical trials.